Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001700452 | SCV002004963 | uncertain significance | not provided | 2023-03-02 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26435059, 31264968) |
Invitae | RCV001700452 | SCV002277365 | uncertain significance | not provided | 2023-10-06 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 832 of the WFS1 protein (p.Arg832Cys). This variant is present in population databases (rs148089728, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with WFS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 592097). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt WFS1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002485847 | SCV002789647 | uncertain significance | Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535807 | SCV004116149 | uncertain significance | WFS1-related disorder | 2023-09-18 | criteria provided, single submitter | clinical testing | The WFS1 c.2494C>T variant is predicted to result in the amino acid substitution p.Arg832Cys. This variant was reported in an individual with type 1 diabetes (Yu et al 2019. PubMed ID: 31264968). This variant is reported in 0.029% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/4-6304016-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Biochemical Molecular Genetic Laboratory, |
RCV000723288 | SCV000854677 | uncertain significance | Cataract 41 | 2018-05-11 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV001700452 | SCV001923584 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001700452 | SCV001963124 | uncertain significance | not provided | no assertion criteria provided | clinical testing |